Ion Beam Applications said it is in a tentative deal to sell its drug discovery unit Cisbio Bioassays to a private equity firm in Europe for $32.5 million. IBA said it is focusing on its core operations involving particle accelerators and radiation therapy. The deal is set to be completed in the coming months.

Full Story:

Related Summaries